Dexcom (Nasdaq:DXCM) today unveiled its next-generation continuous glucose monitor (CGM), the G8 system, at its Investor Day ...
ViCentra announced today that it launched its Kaleido smartphone-controlled hybrid closed-loop insulin delivery system in ...
New system combines Kaleido with Diabeloop’s DBLG2 algorithm and Dexcom G7, with first commercial deliveries in Germany and the Netherlands ...
DexCom boosted its 2026 non-GAAP operating margin guidance to 23%-23.5% after reporting strong Q1 revenue growth and product momentum. Management credited expanded coverage for type 2 non-insulin ...
DexCom posted better-than-expected Q1 2026 results, with revenue up 15% year-over-year on strong uptake of its G7 continuous glucose monitor and expanded coverage for type 2 diabetes patients not ...